EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pulmonary Delivery of siRNA Anti‐TNFα‐loaded Lipid Nanoparticles for Rapid Recovery in Murine Acute Lung Injury

Qinglin Wang, Jihana Achour, Laila Emam, Younes Louaguenouni, Catherine Cailleau, Françoise Mercier-Nomé, Séverine Domenichini iD, Claudine Delomenie, Sezen Gul, Juliette Vergnaud iD, Nicolas Tsapis iD, Arnaud Mansart und 3 weitere

Advanced Healthcare Materials · 2025-11 · 14 (29)

DOI: 10.1002/adhm.202500695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 07.08.2025. Verfasst von Qinglin Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Orsay, 91400, France. Hauptthemen laut MEDLINE: Acute Lung Injury, RNA, Small Interfering, Tumor Necrosis Factor-alpha, Nanoparticles. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Agence Nationale de la Recherche, IHU SEPSIS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates the potential of pulmonary delivery of siRNA as an emergency therapy for acute lung injury (ALI). To obtain a quick anti‐inflammatory response, TNF‐α, a critical pro‐inflammatory cytokine, is knocked down for its early involvement in inflammatory responses. Therefore, TNF‐α siRNA‐lipid nanoparticles (LNPs) are designed and characterized for cellular uptake in lipopolysaccharide (LPS)‐activated RAW264.7 murine macrophages, primary alveolar macrophages, and neutrophils from a murine ALI model. Intracellular trafficking and siRNA cytoplasmic release are evaluated in untreated and LPS‐activated RAW264.7 cells. LPS‐activated cells exhibit a fast and strong uptake of LNPs, including in primary cells. In RAW264.7 cells, significant endosomal escape and siRNA cytoplasmic release are observed after 16 h. In vit ro efficacy studies reveal consistent TNF‐α inhibition across pre‐, co‐, and post‐incubation protocols, confirming the versatility of siRNA‐LNPs in preventive or curative conditions. After intratracheal administration of TNF‐α siRNA‐LNPs in a murine ALI model, the distribution of LNPs demonstrates an accumulation in immune cells, including macrophages and neutrophils, reducing TNF‐α and IL‐6 levels, indicating a rapid anti‐inflammatory effect. This work underscores the efficacy of TNF‐α siRNA‐LNPs in treating lung inflammatory diseases like ALI and highlights the importance of optimizing LNP distribution and delivery timing to enhance therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryRNA, Small InterferingTumor Necrosis Factor-alphaNanoparticlesLipidsAnimalsMiceRAW 264.7 CellsLipopolysaccharidesLungMacrophages, AlveolarMaleDisease Models, AnimalNeutrophils

Stichwörter der Autor:innen

TNF‐αacute lung injurylung deliverynanomedicinesiRNA

Substanzen

RNA, Small InterferingTumor Necrosis Factor-alphaLipopolysaccharidesLipids

Autor:innen und Institutionen

  • Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Orsay, 91400, France.
  • IHU-SEPSIS, Comprehensive Sepsis Center, Raymond Poincaré Hospital (AP-HP), University of Versailles Saint-Quentin en Yvelines, University Paris Saclay, Garches, 92380, France.
  • General Intensive Care Unit, Raymond Poincaré Hospital (AP-HP), University of Versailles Saint-Quentin en Yvelines, University Paris Saclay, Garches, 92380, France.
  • Université Paris-Saclay, UVSQ, INSERM, U1173 2I, Montigny-le-Bretonneux, 78180, France.
  • UMS-IPSIT Plateforme PHIC, Université Paris-Saclay, CNRS, Inserm, Ingénierie et Plateformes au Service de l'Innovation Thérapeutique, Orsay, France.
  • UMS-IPSIT Plateforme MIPSIT, Université Paris-Saclay, CNRS, Inserm, Ingénierie et Plateformes au Service de l'Innovation Thérapeutique, Orsay, France.

ORCID-Profile: Séverine Domenichini, Juliette Vergnaud, Nicolas Tsapis, Djillali Annane, Francois Fay, Elias Fattal

Förderung

  • China Scholarship Council
  • Agence Nationale de la Recherche
  • IHU SEPSIS

Zitieren

APA

Wang, Q., Achour, J., Emam, L., Louaguenouni, Y., Cailleau, C., Mercier-Nomé, F., Domenichini, S., Delomenie, C., Gul, S., Vergnaud, J., Tsapis, N., Mansart, A., Annane, D., Fay, F., & Fattal, E. (2025). Pulmonary Delivery of siRNA Anti‐TNFα‐loaded Lipid Nanoparticles for Rapid Recovery in Murine Acute Lung Injury. Advanced Healthcare Materials, 14(29). https://doi.org/10.1002/adhm.202500695

Vancouver

Wang Q, Achour J, Emam L, Louaguenouni Y, Cailleau C, Mercier-Nomé F, et al. Pulmonary Delivery of siRNA Anti‐TNFα‐loaded Lipid Nanoparticles for Rapid Recovery in Murine Acute Lung Injury. Advanced Healthcare Materials. 2025;14(29). doi:10.1002/adhm.202500695

BibTeX
@article{Wang2025,
  author = {Wang, Qinglin and Achour, Jihana and Emam, Laila and Louaguenouni, Younes and Cailleau, Catherine and Mercier-Nomé, Françoise and Domenichini, Séverine and Delomenie, Claudine and Gul, Sezen and Vergnaud, Juliette and Tsapis, Nicolas and Mansart, Arnaud and Annane, Djillali and Fay, Francois and Fattal, Elias},
  title = {Pulmonary Delivery of siRNA Anti‐TNFα‐loaded Lipid Nanoparticles for Rapid Recovery in Murine Acute Lung Injury},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {29},
  doi = {10.1002/adhm.202500695}
}
Kostenlos starten →